Literature DB >> 2996215

Differentiation between metaplastic carcinomas and sarcomas of the human female breast by fibronectin.

L Christensen, M Nielsen, B Hølund, I Clemmensen.   

Abstract

The distribution pattern of fibronectin in metaplastic carcinomas, stromal sarcomas, malignant cystosarcoma phyllodes tumours and histiocytic type lymphomas of the human female breast has been studied using the indirect immunoperoxidase technique on formalin fixed paraffin embedded tissue. Fibronectin was demonstrated as intensely stained strands between tumour cells forming an irregular network in metaplastic carcinomas and lymphomas. Stromal sarcomas and the malignant stromal component of the phyllodes tumours exhibited, in contrast, a uniform staining throughout tumour cells and stroma which was weaker than in adjacent normal-looking connective tissue. We suggest that the intense staining reaction of metaplastic carcinomas is due to the scirrhous reaction generally associated with invasive human breast carcinomas. The advantage of using fibronectin as a diagnostic tool in the differentiation of carcinoma/lymphoma versus sarcoma is the fact that the antigen is a stromal marker and its staining intensity is not influenced by the morphology or degree of differentiation of non-mesenchymal tumours.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2996215     DOI: 10.1007/bf00709993

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  37 in total

1.  Relationship of histologic features to behavior of cystosarcoma phyllodes. Analysis of ninety-four cases.

Authors:  H J Norris; H B Taylor
Journal:  Cancer       Date:  1967-12       Impact factor: 6.860

2.  Interactions of normal, dysplastic, and malignant mammary epithelial cells with fibronectin in vivo and in vitro.

Authors:  B B Asch; B R Kamat; N A Burstein
Journal:  Cancer Res       Date:  1981-06       Impact factor: 12.701

3.  Sequential appearance of fibronectin and collagen in experimental granulation tissue.

Authors:  M Kurkinen; A Vaheri; P J Roberts; S Stenman
Journal:  Lab Invest       Date:  1980-07       Impact factor: 5.662

4.  Fibronectin in experimental granulation tissue.

Authors:  B Hølund; I Clemmensen; P Junker; H Lyon
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1982-05

5.  Modification of fibronectin distribution pattern in solid human tumours.

Authors:  J Labat-Robert; P Birembaut; L Robert; J J Adnet
Journal:  Diagn Histopathol       Date:  1981 Oct-Dec

Review 6.  Fibronectin in cell adhesion and invasion.

Authors:  E Ruoslahti
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

7.  Carcinoma of the breast with pseudosarcomatous metaplasia.

Authors:  M W Kaufman; J R Marti; H S Gallager; J L Hoehn
Journal:  Cancer       Date:  1984-05-01       Impact factor: 6.860

8.  Immunoperoxidase localization of keratin in human neoplasms: a preliminary survey.

Authors:  R Schlegel; S Banks-Schlegel; J A McLeod; G S Pinkus
Journal:  Am J Pathol       Date:  1980-10       Impact factor: 4.307

9.  Changes in the distribution of fibronectin during limb regeneration in newts using immunocytochemistry.

Authors:  L A Repesh; T J Fitzgerald; L T Furcht
Journal:  Differentiation       Date:  1982       Impact factor: 3.880

10.  Distribution of a major connective tissue protein, fibronectin, in normal human tissues.

Authors:  S Stenman; A Vaheri
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.